Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Janusz, Drzewiecki"'
Autor:
Maciej Pruski, Michał Kozłowski, Krzysztof Milewski, Bartłomiej Orlik, Greg L. Kaluza, Athanasios Peppas, Piotr P. Buszman, Blazej Trela, Juan F. Granada, Janusz Drzewiecki, Paweł Buszman
Publikováno v:
Catheterization and Cardiovascular Interventions. 82:E155-E162
Background The biodegradable polymer drug-eluting stents have been proposed as an alternative to durable polymer DES, theoretically improving vessel healing and reducing the need for prolonged double anti platelet therapy (DAPT), however clinical sig
Autor:
Krysztof Zmudka, Adrian P. Banning, Giulio Guagliumi, Antonio Colombo, Karl Eugen Hauptmann, Stephen Fort, Dariusz Dudek, Eberhard Grube, Mary E. Russell, Sigmund Silber, Francois Schiele, Janusz Drzewiecki
Background— Early clinical studies demonstrated the feasibility of local paclitaxel delivery in reducing restenosis after treatment of de novo coronary lesions in small patient populations. Methods and Results— We conducted a randomized, double-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8b94b66a1448d9e1cf1595af09b4d55
https://doi.org/10.1161/01.cir.0000086926.62288.a6
https://doi.org/10.1161/01.cir.0000086926.62288.a6
Autor:
Adam, Witkowski, Pawel, Maciejewski, Wojciech, Wasek, Lukasz A, Malek, Maciej, Niewada, Bogumil, Kaminski, Janusz, Drzewiecki, Maciej, Kosmider, Jacek, Kubica, Witold, Ruzyllo, Jan Z, Peruga, Dariusz, Dudek, Grzegorz, Opolski, Slawomir, Dobrzycki, Robert J, Gil, Bogdan, Januś
Publikováno v:
European Heart Journal. 30:1736-1743
Aims The aim of this analysis was to examine the influence of different in-cath-lab antiplatelet regimens for the primary percutaneous coronary intervention (PCI) on all-cause mortality. Methods and results The study group consisted of 7193 patients
Autor:
Adrian P. Banning, Dariusz Dudek, Patrick W. Serruys, Gerrit Anne van Es, Nico Bruining, Zheng Zhou, Keiichi Tsuchida, Mary E. Russell, Tessa Rademaker, Joerg Koglin, Janusz Drzewiecki, Antonio Colombo, Krzysztof Zmudka, Francois Schiele
Publikováno v:
American Journal of Cardiology, 99(5), 607-615. Elsevier Inc.
Late loss has been used as a reliable surrogate end point for evaluation and differentiation of short-term performance of drug-eluting stents. This study investigated the consistency between angiographic and intravascular ultrasound (IVUS) outcomes o
Autor:
Jiro Aoki, Antonio Colombo, Janusz Drzewiecki, Patrick W. Serruys, Krzysztof Zmudka, Dariusz Dudek, Joerg Koglin, Francois Schiele, Adrian P. Banning, Mary E. Russell
Publikováno v:
Circulation, 112(25), 3876-3883. Lippincott Williams & Wilkins
Background— The purpose of this study was to evaluate long-term vascular responses as long as 2 years after implantation of polymer-based, paclitaxel-eluting stents in contrast to uncoated stents. Methods and Results— TAXUS II is a randomized, do
Autor:
Johannes J. R. M. Bonnier, Ronald Hamers, Muzaffer Degertekin, Karl Eugen Hauptmann, Clemens Disco, Jurgen Ligthart, Patrick W. Serruys, Hans R. Figulla, Angela Hoye, Jean Michel Lablanche, Jan Erik Nordrehaug, Tomasz Siminiak, Nico Bruining, Kengo Tanabe, Dariusz Dudek, Jörg Koglin, Wilhelm Urbaszek, Adrian P. Banning, Antonio Colombo, Janusz Drzewiecki, Eberhard Grube, Giulio Guagliumi, Mary E. Russell
Publikováno v:
Circulation, 111(7), 900-905. Lippincott Williams & Wilkins
Background— The clinical impact of late incomplete stent apposition (ISA) for drug-eluting stents is unknown. We sought to prospectively investigate the incidence and extent of ISA after the procedure and at 6-month follow-up of paclitaxel-eluting
Autor:
Sigmund Silber, Janusz Drzewiecki, Wolfgang Rutsch, Krzysztof Zmudka, Antonio Colombo, John G. Webb, Karl Hauptman, Matthias Pfisterer, Jörg Koglin, Christoph A. Nienaber, Keith D. Dawkins, Eberhard Grube, Jaap Hamburger, Jorge Belardi
Publikováno v:
Herz. 29:171-180
Although direct coronary stenting does not improve angiographic outcome, it makes sense by reducing procedure times, radiation exposure and costs. Other potential advantages of direct stenting may be a reduction of myocardial ischemia time, which cou
Autor:
Michał Szczeklik, Andrzej Bochenek, Marek Cisowski, Wojciech Kruczak, Andrzej Jaklik, Janusz Drzewiecki, Agnieszka Drzewiecka-Gerber
Publikováno v:
Scopus-Elsevier
Background Percutaneous revascularization is a well-accepted method of treatment for a single left anterior descending coronary artery (LAD) stenosis. With the introduction of primary stenting, it has become the treatment of choice for a LAD lesion.
Autor:
Zbigniew Purzycki, Andrzej Lekston, Adam Witkowski, Barbara Górecka, Robert J. Gil, Piotr Pieniazek, Janusz Drzewiecki, Mariusz Gasior, Dariusz Ciećwierz, Maciej Kośmider, Zygmunt Sadowski, Lech Poloński, Paweł Buszman, Witold Rużyłło, Krzysztof Żmudka
Publikováno v:
American Heart Journal. 140:264-271
Background Previous randomized trials have shown beneficial effects of coronary stenting on restenosis and event–free survival rates. However, it has not yet been fully established if routine high–pressure stenting with an antiplatelet regimen ca
Publikováno v:
Circulation: Cardiovascular Interventions. 1:82-84
A 75-year-old man was transferred to our department from the local hospital because of recurrent episodes of dyspnea and angina at rest, with significant 3.0-mV ST-segment depressions in ECG leads V3 through V6. His medical history was significant fo